Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations

This cohort study evaluates stroke and major bleeding rates before and after switching from warfarin to a direct oral anticoagulant (DOAC) in patients grouped by pre-switch time-in-therapeutic range guideline thresholds.

Detalles Bibliográficos
Autores principales: Haymart, Brian, Barnes, Geoffrey D., Kong, Xiaowen, Ali, Mona, Kline-Rogers, Eva, DeCamillo, Deborah, Kaatz, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284330/
https://www.ncbi.nlm.nih.gov/pubmed/35834255
http://dx.doi.org/10.1001/jamanetworkopen.2022.22089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284330/
https://www.ncbi.nlm.nih.gov/pubmed/35834255
http://dx.doi.org/10.1001/jamanetworkopen.2022.22089

Ejemplares similares